Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation
Citations Over TimeTop 10% of 2016 papers
Abstract
Lung transplant recipients (LTR) are at high risk of cutaneous squamous cell carcinoma (SCC). Voriconazole exposure after lung transplant has recently been reported as a risk factor for SCC. We sought to study the relationship between fungal prophylaxis with voriconazole and the risk of SCC in sequential cohorts from a single center. We evaluated 400 adult LTR at UCLA between 7/1/2005 and 12/22/2012. On 7/1/2009, our center instituted a protocol switch from targeted to universal antifungal prophylaxis for at least 6 months post-transplant. Using Cox proportional hazards models, time to SCC was compared between targeted (N = 199) and universal (N = 201) prophylaxis cohorts. Cox models were also used to assess SCC risk as a function of time-dependent cumulative exposure to voriconazole and other antifungal agents. The risk of SCC was greater in the universal prophylaxis cohort (HR 2.02, P < 0.01). Voriconazole exposure was greater in the universal prophylaxis cohort, and the cumulative exposure to voriconazole was associated with SCC (HR 1.75, P < 0.01), even after adjustment for other important SCC risk factors. Voriconazole did not increase the risk of advanced tumors. Exposure to other antifungal agents was not associated with SCC. Voriconazole should be used cautiously in this population.
Related Papers
- → The Optimal Procedure for Retransplantation After Single Lung Transplantation(2017)20 cited
- → Review of patient outcomes of aspergillus prophylaxis with voriconazole after lung transplantation(2005)10 cited
- → 198: Patients over 75 years of age with and without atrial fibrillation: characteristics and differences in a hospital cohort of 357 patients(2013)
- → 203 Choice of arterial access and outcomes in patients referred for percutaneous coronary intervention in an all comers cohort(2011)
- → 16-13: Comparision of Outcomes of Atrial Fibrillation Ablation Procedures between an Octagenerian cohort of patients and an Young-Old cohort of patients(2016)